Skip to content
Screener

Rigel Pharmaceuticals RIGL Cash Flow Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
$848K+39.7%$597K-1.2%$601K-0.5%$603K-1.3%$607K-1.0%
$6.84M+109%$3.46M+4.0%$2.75M+31.7%$3.36M+27.2%$3.28M+29.6%
$30.65M+0.4%$2.73M+405%$21.98M+7,178%$24.03M+10.8%$30.54M—
————$1.25M0.0%$1.25M0.0%$1.25M0.0%
$17.45M+175%-$7.98M+24.4%-$25.36M—-$33.18M-973%-$23.28M-313%
$511K—$3.74M—————$0—
$47.75M—$7.5M—————$0—
-$11.7M-2,899%-$10.92M-2,356%——$4.27M+143%$418K+156%
$36.41M—-$16.17M-47.5%-$7.95M-257%-$4.87M-131%——

FAQ

How much cash does Rigel Pharmaceuticals generate?
Rigel Pharmaceuticals (RIGL) generated $79.4M in operating cash flow over the trailing twelve months.
Where does Rigel Pharmaceuticals's cash flow data come from?
Every line is extracted from Rigel Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.